Financial reports
10-K/A
2023 FY
Annual report (amended)
26 Apr 24
10-K
2023 FY
Annual report
29 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
29 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
Current reports
8-K
Regulation FD Disclosure
15 Apr 24
8-K
Other Events
4 Mar 24
8-K
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial
4 Mar 24
8-K
Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial Highlights
8 Jan 24
8-K
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
8 Nov 23
8-K
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results
9 Aug 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3 Aug 23
8-K
Departure of Directors or Certain Officers
3 Aug 23
8-K
Regulation FD Disclosure
5 Jun 23
8-K
Other Events
31 May 23
Registration and prospectus
8-A12B
Registration of securities on exchange
15 Apr 24
424B5
Prospectus supplement for primary offering
30 Mar 23
424B5
Prospectus supplement for primary offering
29 Mar 23
S-3
Shelf registration
31 Aug 22
S-8
Registration of securities for employees
16 Mar 22
S-8
Registration of securities for employees
10 Feb 21
424B3
Prospectus supplement
24 Jun 20
S-3
Shelf registration
1 May 20
424B5
Prospectus supplement for primary offering
29 Apr 20
424B5
Prospectus supplement for primary offering
28 Apr 20
Proxies
DEFR14A
Revised proxy
5 Jun 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
15 Jun 22
DEFR14A
Revised proxy
15 Jun 22
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFR14A
Revised proxy
4 Jun 21
DEFA14A
Additional proxy soliciting materials
30 Apr 21
DEF 14A
Definitive proxy
30 Apr 21
Other
EFFECT
Notice of effectiveness
13 Sep 22
UPLOAD
Letter from SEC
8 Sep 22
CORRESP
Correspondence with SEC
8 Sep 22
UPLOAD
Letter from SEC
25 Jan 21
CORRESP
Correspondence with SEC
24 Nov 20
UPLOAD
Letter from SEC
29 Oct 20
CORRESP
Correspondence with SEC
14 Oct 20
UPLOAD
Letter from SEC
22 Sep 20
CORRESP
Correspondence with SEC
26 Aug 20
UPLOAD
Letter from SEC
12 Aug 20
Ownership
4
Richard J Kim
4 Mar 24
4
THOMAS S MCHUGH
4 Mar 24
4
Gregory J Divis
4 Mar 24
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 24
SC 13G/A
JANUS HENDERSON GROUP PLC
13 Feb 24
SC 13G/A
GENDELL JEFFREY L
13 Feb 24
SC 13G
Polar Capital Holdings Plc
13 Feb 24
SC 13G/A
KOTLER KEVIN
12 Feb 24
4
THOMAS S MCHUGH
16 Jan 24
4
Mark Anthony McCamish
29 Dec 23